Search Results

Research Study Search Results

1. Cancer (Oncology)

   1. When Mommy or Daddy Get Cancer: A Cancer Parenting Program Frances M. Lewis, PhD, RN, FAAN
   2. Psychoeducation for Spouses of Women with Breast Cancer Frances M. Lewis, PhD, RN, FAAN (University of Washington)

   1. Breast

      1. SWOG 1105: Randomized Trial Of Text-Messaging Intervention To Reduce Early Discontinuation Of Adjuvant Aromatase Inhibitor Therapy In Women With Early Stage Breast Cancer Gary Goodman, M.D.
      2. SWOG 1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II Gary Goodman, M.D.
      3. SWOG 1007: A Phase III Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less Gary Goodman, M.D.
      4. SWOG 0927: Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer, Phase III Gary Goodman, M.D.
      5. CTSU E3108: A Phase II Prospective Trial Correlating Progression Free Survival with CYP2D6 Activity in Patients with Metastatic Breast Cancer Treated with Single Agent Tamoxifen Gary Goodman, M.D.
      6. CTSU E2108: A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Christine Lee, M.D.
      7. CTSU C40603: Randomized Phase II 2 X 2 Factorial Trial Of The Addition Of Carboplatin +/- Bevacizumab To Neoadjuvant Weekly Paclitaxel Followed By Dose-Dense AC In Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer Gary Goodman, M.D.
      8. CTSU B-49: A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer Gary Goodman, M.D.
      9. CTSU B-47: A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of TC or Four Cycles of AC Followed by Four Cycles of Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-N Gary Goodman, M.D.
      10. CTSU B-43: A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy Gary Goodman, M.D.
      11. CRC 11105: Prevention of Recurrence in Early-Stage,Node-Positive Breast Cancer With Low to Intermediate HER2 Expressions With NeuVax(TM) Treatment Kristine Rinn, M.D. and Henry Kaplan, M.D.
      12. CRC 10016: I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2) Erin Ellis, M.D. and Henry Kaplan, M.D.
      13. CRC 09139: A Randomized, Phase III Study of Lapatinib plus Trastuzumab vs Trastuzumab as Continued HER2 Suppression Therapy after Completion of 1st- or 2nd-line Trastuzumab plus Chemotherapy in Subjects with HER2-positive Metastatic Breast Cancer Erin Ellis, M.D.

   2. Cancer Control

      1. SWOG 0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients with Bone Metastases Starting Zoledronic Acid Treatment Gary Goodman, M.D.

   3. Cancer Detection Program

      1. Ovarian Cancer Early Detection Program Pamela Paley, M.D.
      2. Flight Attendants Medical Research Institute (FAMRI) – International Early Lung Cancer Action Program (IELCAP) Protocol Ralph Aye, M.D.

   4. Colon

      1. SWOG 0820: A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon Cancer, Phase III Gary Goodman, M.D.
      2. CTSU C80702: A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer Gary Goodman, M.D.

   5. Colorectal

      1. SWOG 1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II Gary Goodman, M.D.
      2. SWOG 0518: Phase III Prospective Randomized Comparison of Depot Octreotide plus Interferon Alpha versus Depot Octreotide plus Bevacizumab in Advanced, Poor Prognosis Carcinoid Patients Gary Goodman, M.D.
      3. CRC 10097: Phase Ib with Expansion of Patients at the MTD Study of AUY922 and Cetuximab in Patients with KRAS Wild-Type Metastatic Colorectal Cancer Philip Gold, M.D.

   6. Endometrial

      1. Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery Pamela Paley, M.D.

   7. Esophageal

      1. SWOG 1201: A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1 (Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric, or Gastroesophageal Junction (GEJ) Cancer Gary Goodman, M.D.

   8. Fallopian tube

      1. CRC 11106: A Randomized, Double-Blinded, Placebo-Controlled Trial of Cvac as Maintenance Treatment in Patients With EOC in CR Following First-Line Chemotherapy Saul Rivkin, M.D.

   9. Gallbladder or Bile Duct

   10. Gastroesophageal Junction

       1. SWOG 1201: A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1 (Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric, or Gastroesophageal Junction (GEJ) Cancer Gary Goodman, M.D.

   11. Gynecologic

       1. CRC 11006: Phase I Trial of Intraperitoneal nab-Paclitaxel (Abraxane®) in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity Saul Rivkin, M.D.

   12. Kidney

       1. SWOG 1107: Parallel (Randomized) Phase II Evaluation of ARQ 197 and ARQ 197 in Combination With Erlotinib in Papillary Renal Cell Carcinoma Gary Goodman, M.D.
       2. SWOG 0931: EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study Gary Goodman, M.D.

   13. Leukemia

       1. SWOG 1203: A Randomized Phase III Study of Standard Cytarabine Plus Daunomycin (7+3) Therapy versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML) Gary Goodman, M.D.
       2. SWOG 0919: A Phase II Study of Idarubicin and Ara-C in Combination with Pravastatin for Poor-Risk Acute Myelogenous Leukemia (AML) Gary Goodman, M.D.
       3. SWOG 0805: Phase II Study of Combination of Hyper-CVAD and Dasatinib With or Without Allogeneic Stem Cell Transplant in Patients With Philadelphia (Ph) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL) (a BMT Study) Gary Goodman, M.D.
       4. CRC 11060: Studying Interventions for Managing Patients with Chronic Myeloid Leukemia in Chronic Phase I: The 5-Year Prospective Cohort Study (SIMPLICITY) Kenneth Kraemer, M.D.

   14. Liver

       1. CTSU E1208: A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion Gary Goodman, M.D.
       2. CRC 12140: SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Subjects Who Failed Prior Treatment With Sorafenib Philip Gold, M.D.

   15. Lung

       1. SWOG 0905: Randomized Phase II Study of Cediranib (NSC #732208) Versus Placebo in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Malignant Pleural Mesothelioma Gary Goodman, M.D.
       2. SWOG 0819: Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Gary Goodman, M.D.
       3. CTSU E1505: A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Gary Goodman, M.D.
       4. CTSU C30801: A Randomized Phase III Double Blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced Non-Small Cell Lung Cancer Gary Goodman, M.D.
       5. CTSU C140503: A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small (<=2 cm) Peripheral Non-Small Cell Lung Cancer Gary Goodman, M.D.
       6. CRC 12127: LUX-Lung EAP US: An open label expanded access program of afatinib (BIBW 2992) for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR mutation(s) Howard (Jack) West, M.D.
       7. CRC 12110: A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects with Solid Tumors Howard (Jack) West, M.D.
       8. CRC 12104: A Phase I/II Study of the ALK Inhibitor CH5424802 in Patients with ALK-Rearranged Non-Small Cell Lung Cancer Howard (Jack) West, M.D.
       9. CRC 12090: An Open-Label Randomized Phase III Trial of BMS-936558 Versus Docetaxel in Previously Treated Metastatic Non-Squamous Cell Non-small Cell Lung Cancer (NSCLC) Howard (Jack) West, M.D.
       10. CRC 12071: An Open-Label Randomized Phase III Trial of BMS-936558 Versus Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) Howard (Jack) West, M.D.
       11. CRC 12058: A Phase 1, Open-Label, Multiple-Ascending-Dose Study of DS-2248, an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Subjects With Advanced Solid Tumors Howard (Jack) West, M.D.
       12. CRC 12046: A Randomized Study of Palifosfamide-tris in Combination with Carboplatin and Etoposide (PaCE) Chemotherapy vs Carboplatin and Etoposide (CE) Alone in Chemotherapy Naive Patients with Extensive-Stage Small Cell Lung Cancer Howard (Jack) West, M.D.
       13. CRC 11090: (ARCHER 1042 Study) A Phase 2, Multi-Cohort Study To Evaluate The Impact Of Prophylactic Intervention On Dermatologic And Gastrointestinal Adverse Events And Patient Reported Outcomes In Patients Treated With Dacomitinib (PF-00299804) Howard (Jack) West, M.D.
       14. CRC 09023: Collaborative Study on Sputum Cytology of Lung-Cancer Patients by the Swedish Cancer Institute and VisionGate, Inc Ralph Aye, M.D.

   16. Lymphoma

       1. SWOG 1106: Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma Gary Goodman, M.D.
       2. SWOG 1001: A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL) Gary Goodman, M.D.
       3. SWOG 0806:A Phase I/II Trial of Vorinostat (SAHA) (NSC-701852) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) Gary Goodman, M.D.
       4. SWOG 0711: Phase I Pharmacokinetic Study of Dasatinib (BMS-354825) (NSC-732517; IND-73969) in Patients With Advanced Malignancies and Varying Levels of Liver Dysfunction Gary Goodman, M.D.

   17. Melanoma

       1. CTSU E1609: A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a-2b for Resected High-Risk Melanoma Gary Goodman, M.D.

   18. Myeloproliferative Disorders

       1. CRC 11122: A Phase 2 Study of LY2784544 in Patients with Myeloproliferative Neoplasms Michael Milder, M.D.

   19. Neuroendocrine

       1. SWOG 0518: Phase III Prospective Randomized Comparison of Depot Octreotide plus Interferon Alpha versus Depot Octreotide plus Bevacizumab in Advanced, Poor Prognosis Carcinoid Patients Gary Goodman, M.D.

   20. Ovarian

       1. CRC 11114: Phase Ib with Expansion of Patients at the MTD Study of Olaparib plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients Saul Rivkin, M.D.
       2. CRC 11106: A Randomized, Double-Blinded, Placebo-Controlled Trial of Cvac as Maintenance Treatment in Patients With EOC in CR Following First-Line Chemotherapy Saul Rivkin, M.D.

   21. Pancreas

       1. SWOG 1115: Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate and MK-2206 vs. mFOLFOX in Patients with Metastatic Pancreatic Cancer after Prior Chemotherapy Gary Goodman, M.D.

   22. Peritoneal

       1. CRC 11106: A Randomized, Double-Blinded, Placebo-Controlled Trial of Cvac as Maintenance Treatment in Patients With EOC in CR Following First-Line Chemotherapy Saul Rivkin, M.D.
       2. CRC 11006: Phase I Trial of Intraperitoneal nab-Paclitaxel (Abraxane®) in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity Saul Rivkin, M.D.

   23. Prostate

       1. SWOG 1014: Abiraterone Acetate Treatment for Prostate Cancer Patients with a PSA of More Than Four Following Initial Androgen Deprivation Therapy, Phase II Gary Goodman, M.D.
       2. CRC 12061: A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer Howard (Jack) West, M.D.

   24. Renal

       1. CTSU C90601: A Randomized Doubled-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma Gary Goodman, M.D.

   25. Solid Tumor

       1. SWOG 0711: Phase I Pharmacokinetic Study of Dasatinib (BMS-354825) (NSC-732517; IND-73969) in Patients With Advanced Malignancies and Varying Levels of Liver Dysfunction Gary Goodman, M.D.
       2. SWOG 0518: Phase III Prospective Randomized Comparison of Depot Octreotide plus Interferon Alpha versus Depot Octreotide plus Bevacizumab in Advanced, Poor Prognosis Carcinoid Patients Gary Goodman, M.D.
       3. CRC 11120: A Phase 1, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Adult Subjects with Advanced Solid Tumors Philip Gold, M.D.

   26. Solid Tumor or Hematologic Malignancy

       1. CRC 11055: A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy Henry Kaplan, M.D.

   27. Stomach

       1. SWOG 1201: A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1 (Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric, or Gastroesophageal Junction (GEJ) Cancer Gary Goodman, M.D.
       2. SWOG 0518: Phase III Prospective Randomized Comparison of Depot Octreotide plus Interferon Alpha versus Depot Octreotide plus Bevacizumab in Advanced, Poor Prognosis Carcinoid Patients Gary Goodman, M.D.

2. End of Life

   1. Reducing Health Disparities at End-of-Life Ardith Doorenbos, PhD, RN

3. Headache/Migraine

   1. Headache/Migraine

      1. Aspirin Resistance in Women with Migraine Jill Jesurum, PhD

4. Heart & Vascular

   1. Cardiac Surgery

      1. RED CELL STORAGE DURATION STUDY (RECESS) David M. Gartman, MD
      2. CorMatrix Glenn R. Barnhart, MD
      3. ABLATE-AF Registry Trial Glenn R. Barnhart, MD

   2. Electrophysiology

      1. MultiSENSE: Multisensor Chronic Evaluations in Ambulatory Heart Failure Darryl Wells, MD
      2. LSR of ACUITY SPIRAL - LONGITUDINAL SURVEILLANCE REGISTRY OF THE ACUITY SPIRAL LEAD Darryl Wells, MD
      3. Clinical Evaluation of the Blazer Open-Irrigated Radiofrequency Ablation Catheter for the Treatment of Type 1 Atrial Flutter – BLOCK-CTI Darryl Wells, MD
      4. CABANA Study Darryl Wells, MD

   3. Interventional Cardiology Trials

      1. TRYTON Mark Reisman, MD
      2. Early Recognition & Treatment of STEMI - Angel Medical Systems Guardian implant to detect ST shifts and other cardiac irregularities and alert subject to seek medical attention (ALERTS) Jeffrey Westcott, MD
      3. COLOR Observational Registry John Petersen II, MD
      4. A study to evaluate the RenalGuard System safety & efficacy when compared with standard care in the prevention of contrast induced nephropathy in the setting of a catheterization laboratory. Paul Huang, MD
      5. A clinical trial comparing Cangrelor to Clopidogrel standard of care therapy in subjects who require percutaneous coronary intervention: CHAMPION PHOENIX John Petersen II, MD

   4. Other Trials

      1. Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation. Elizabeth Perpetua, MN, RN, ARNP, CCRN
      2. REAL-ICU Sandeep Sachdeva, MD
      3. Patient and Partner Intervention to Improve Outcomes After an Implantable Cardioverter Defibrillator (ICD) Cynthia M. Dougherty, ARNP PhD

   5. Peripheral Trials

      1. Pressure and Imaging Using the Cardiomems Endosure Sensor for Long-term Follow-up after EVAR with Standard Surveillance (PRICELESS – Prospective Registry) Robert Bersin, MD
      2. Abbot RX Acculink with RX Accunet OR Xact stent with Emboshield (CHOICE) Robert Bersin, MD

   6. Pharma Clinical Trials

      1. HokusaiVTE Sandeep Sachdeva, MD
      2. EXCITE: Excimer Laser Randomized Controlled Study for Treatment of Femoropopliteal In-Stent Restenosis. Robert Bersin, MD
      3. CANTOS- Phase 3, randomized, double-blind, placebo controlled study of quarterly injections of canakinumab Paul Huang, MD

   7. Structural Heart Trials

      1. Percutaneous Mitral Valve Repair – Continued Access Registry for the Evalve Inc. MitraClip system for patients with 3+/4+ mitral regurgitation. (REALISM) Mark Reisman, MD
      2. Left Atrial Appendage Closure for Atrial Fibrillation – PREVAIL Mark Reisman, MD

   8. Vascular Surgery

      1. Comparison of Safety and Primary Patency Between FUSION Vascular Graft with Bioline and Exxcel ePTFE Kaj Johansen, MD

5. HIV/AIDS

   1. A randomized, double-blind study comparing two different treatment regimens for HIV-infected patients. Peter Shalit, MD PhD

6. Kidney/Dialysis

   1. Other

      1. Hemodialysis Fistual Maturation Consortium Study Jonathan Himmelfarb, MD

7. Macular Degeneration

   1. Study of the Efficacy and Safety of a Drug for Subjects with Minimally Classic or Occult Subfoveal Neovascular Age-Related Macular Degeneration Craig G. Wells, M.D.

8. Neuroscience

   1. Brain Tumor

      1. The Ivy Glioblastoma Atlas Project: A Multi-site Initiative to Create a Web-based Resource for Glioblastoma Research. Greg Foltz, MD
      2. Phase 1 Study of the Metabolism and Distribution of a Subpharmacologic Dose of Lightly-labeled 14CTemozolomide in Newly Diagnosed Glioblastoma Patients Greg Foltz, MD
      3. A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM John Henson, MD
      4. A Phase II Clinical Trial Evaluating DCVax®-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme Greg Foltz, MD

   2. Brain Tumor /Neuroendocrine

      1. Efficacy and safety of pasireotide LAR in patients with rare tumors of neuroendocrine origin William H. Ludlam, MD

   3. Brain Tumor /Neurosurgery

      1. The Comprehensive Neuro-Oncology Data Repository (CONDR): Prospective Collection of Clinical Tissue and Imaging Data for the Study of Patients with Brain Tumors. Sarah C. Jost, MD

   4. Craniotomy /Interventional

      1. Intravenous acetaminophen for craniotomy patients Arthur M. Lam, M.D.

   5. Epilepsy

      1. Tissue Procurement and Repository for Future Neuroscience Studies Ryder Gwinn, MD
      2. Responsive Neurostimulator (RNS) System - Long-term Treatment Clinic Investigation Ryder Gwinn, MD
      3. A combined FMRI and electrophysiological study of human sensory perception Jehuda P Sepkuty, MD

   6. Epilepsy /Genetic

      1. Protocol For Research of Genetic Epilepsy Marcio Sotero de Menezes, MD

   7. Multiple Sclerosis

      1. XenoPort Arbaclofen Study Angeli Mayadev, MD
      2. Temporal gene expression and microRNA profiling in the blood of patients with demyelinating disease treated with steroids. James Bowen, MD
      3. Pain Research in Multiple Sclerosis (PRIME) Angeli Mayadev, MD
      4. JCV Antibody Program in patients with Relapsing MS and who are Receiving or Considering Treatment with Tysabri Lily Jung, MD
      5. Fingolimod (FTY720) Lily Jung, MD
      6. Double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of teriflunomide versus placebo in patients with a first clinical episode suggestive of multiple sclerosis Pavle Repovic, MD, PhD
      7. Double-blind placebo-controlled parallel-group study to evaluate the safety and efficacy of two doses of oral Dalfampridine extended release tablets (5 mg and 10 mg twice daily) in patients with Multiple Sclerosis Angeli Mayadev, MD
      8. Diogenix - MS Specificity James Bowen, MD
      9. CLINICAL CROSS RELAXATION IMAGING AT 3 TESLA MAGNET FIELD STRENGTH METHODOLOGY DEVELOPMENT AND APPLICATION TO MULTIPLE SCLEROSIS Lily Jung Henson, MD
      10. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis Pavle Repovic, MD, PhD
      11. A multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients with Relapsing Multiple Sclerosis. Lily Jung, MD
      12. 109MS301 - A Randomized, Multi-center, Double-blind, Placebo-controlled, Dose-comparison Study to Determine the Efficacy and Safety of BG00012 in Subjects with Relapsing-Remitting Multiple Sclerosis (RRMS) Lily Jung, MD
      13. 101MS402 TYGRIS - Tysabri Global Observational Program in Safety Lily Jung, MD

   8. Neuro-Ophthalmology

      1. Pfizer NAION Eugene May, MD
      2. NORDIC IIHTT Steven Hamilton, MD

   9. Neuro-Otology

      1. Electric-Acoustic System (EAS) Douglas D Backous, MD

   10. Pituitary

       1. VRS317 William H. Ludlam, MD
       2. Pasireotide/SOM230C (Acromegaly) William Ludlam, MD
       3. Cushing's LAR. CSOM230G2304 William H. Ludlam, MD
       4. CSOM230B (Cushing's) William Ludlam, MD

   11. Pituitary Tumor /Acromegaly

       1. Assess safety and efficacy of double-blind pasireotide LAR 40 mg and pasireotide LAR 60 mg versus openlabel octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly William H. Ludlam, MD

   12. Psychiatry

       1. A clinical evaluation for the management of patients with major depressive disorder, single or recurrent episode, with deep brain stimulation Ken Melman, MD

   13. Spine

       1. The EMPOWER study: Eon Mini™ Study - Product Options for Wellness, Effectiveness, and Relief; A Multi-Centered Evaluation of Patients with Chronic Pain of the Trunk and/or Limbs using Paddle Lead(s). Ryder Gwinn, MD
       2. Prospective Randomized Investigation of Radiofrequency Targeted Vertebral Augmentation (The PRIORi-T Trial) Glen David, MD
       3. 'Evidence' study-Spinal Cord Stimulation with Precision SCS System versus Reoperation Ryder Gwinn, MD

   14. Stroke

       1. Ultrasound and Systemic Tissue Plasminogen Activator for Emergent Revascularization in Acute Ischemic Stroke William Likosky, MD
       2. Carotid Occlusion Surgical Study (COSS) David W. Newell, MD
       3. A RANDOMIZED DOUBLE-BLIND PARALLEL-GROUP PLACEBO-CONTROLLED PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DESMOTEPLASE IN PATIENTS WITH ACUTE ISCHEMIC STROKE-"DIAS-4" William Likosky, MD

9. Ophthalmology

   1. Study of the Efficacy and Safety of a Drug for Subjects with Minimally Classic or Occult Subfoveal Neovascular Age-Related Macular Degeneration Craig G. Wells, M.D.

10. Perinatal Studies

    1. Perinatal Research

       1. PRE-CONCEPTIONAL COHORT STUDY OF METABOLIC ABNORMALITIES IN RELATION TO INCIDENT PREECLAMPSIA AND PRETERM DELIVERY IN CHINA Michelle Williams, ScD
       2. Omega Study - Epidemiology of Marine Fatty Acids and Preeclampsia (CLOSED TO ENROLLMENT; FOLLOW-UP ONGOING) Michelle Williams, ScD
       3. Epidemiology of Abruptio Placentae in Peru (ENROLLMENT CLOSED; DATA ANALYSIS ONLY) Michelle Williams, ScD
       4. AMBIENT AIR POLLUTION, PREECLAMPSIA, AND PRETERM DELIVERY (CLOSED TO ENROLLMENT; DATA ANALYSIS ONLY) Michelle Williams, ScD

11. Prostate Cancer Prevention

    1. Study Evaluating the Safety and Efficacy of a Drug Used to Reduce the Risk of Biopsy-Detectable Prostate Cancer James Tremann, M.D.

12. Rheumatology Research

    1. Systemic Lupus Erythematosis (SLE)

       1. A study of the effectiveness and safety of Epratuzumab in Systemic Lupus Erythematosis (SLE) (EMBODY) Philip J. Mease, MD
       2. A placebo controlled study to evaluate the safety and efficacy of subcutaneous injection LY2127399 in Systemic Lupus Erythematosus (SLE).(Illuminate study). Philip J. Mease, MD

13. Sleep Medicine

    1. Sleep Apnea

       1. Effects of Inspire Implantable Nerve Stimulation System on Obstructive Sleep Apnea. Sarah Stolz, MD